 WALTHAM, Mass., Nov. 18, 2020 GLOBE NEWSWIRE -- Eloxx Pharmaceuticals, Inc. NASDAQ: ELOX, a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic fibrosis and other diseases caused by nonsense mutations limiting production of functional proteins, is pleased to announce that Dr. Gregory Williams, Chief Executive Officer of Eloxx, will participate in a fireside chat and host one-on-one meetings with investors at the Piper Sandler 32 nd Annual Virtual Growth C onference. The fireside chat will be available on the Piper Sandler Conference website to registered attendees on November 23rd at 10:00 AM ET to December 3, 2020. 